in patients with chronic rhinosinusitis with nasal polyps (CRSwNP). The therapy met the co-primary endpoint of the WAYPOINT ...

Results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps showed that AstraZeneca (AZN) and ...

(IN BRIEF) A Phase III trial of Tezspire (tezepelumab) by AstraZeneca and Amgen has shown significant benefits for patients ...

Amgen (AMGN) and AstraZeneca (AZN) announced top-line results from the Phase 3 WAYPOINT trial in patients with chronic rhinosinusitis with ...

November 08, 2024--(BUSINESS WIRE)--Positive high-level results from the Phase III WAYPOINT trial in patients with chronic rhinosinusitis with nasal polyps (CRSwNP ... significant and clinically ...

Amgen (AMGN) and AstraZeneca's (AZN) asthma therapy Tezspire hits main goals in the Phase 3 trial for chronic rhinosinusitis ...

AstraZeneca PLC on Friday said it received positive results from a trial of Tezspire as a treatment for chronic rhinosinusitis with nasal polyps. Chronic rhinosinusitis is a disorder characterised by ...

A sinus infection, also known as sinusitis, occurs when the air cavities around your nasal passages become inflamed and ...

Taking care of your ears, nose, and throat (ENT) is essential, especially in an environment with rising air and noise pollution. Prolonged exposure to pollutants can lead to long-term health issues.

A deviated septum occurs when you have two different-sized nasal passageways which can cause one-sided congestion.

While those with pre-existing conditions like chronic obstructive pulmonary disease (COPD ... "Post-Covid, many people have lingering lung issues which reduces their capacity to cope with pollution.

Aggarwal said such patients are experiencing a drop in oxygen saturation and breathing difficulties due to the rising ...